Literature DB >> 11113315

Developmental regulation of tryptophan hydroxylase messenger RNA expression and enzyme activity in the raphe and its target fields.

H B Rind1, A F Russo, S R Whittemore.   

Abstract

Tryptophan hydroxylase is the rate-limiting enzyme in the synthesis of serotonin and during development, brain serotonin levels and tryptophan hydroxylase activities increase. Increased tryptophan hydroxylase activity could result from alterations in tryptophan hydroxylase messenger RNA levels, translation, and/or post-translational regulation. Tryptophan hydroxylase messenger RNA levels in the dorsal raphe nucleus increased 35-fold between embryonic day 18 and postnatal day 22, measured by quantitative in situ hybridization, then decreased by 40% between postnatal days 22 and 61. These changes correlated with tryptophan hydroxylase enzyme activities in the raphe nuclei as expected, but not in cortical or hippocampal targets. Tryptophan hydroxylase messenger RNA expression in the nucleus raphe obscuris increased 2.5-fold between postnatal days 8 and 22 but did not correlate with enzyme activity in the spinal cord. Using an in vitro model of serotonergic raphe neuron differentiation, serotonergic differentiation was associated with an increase in both tryptophan hydroxylase promoter activity and protein expression. In vivo, tryptophan hydroxylase messenger RNA levels per single cell and per brain section were correlated during development up to postnatal day 22, but not beyond for both the dorsal raphe nucleus and nucleus raphe obscuris. Between postnatal days 22 and 61 single cell levels of tryptophan hydroxylase messenger RNA in the dorsal raphe nucleus did not change yet the levels per brain section significantly decreased by 40%. During the same period in the nucleus raphe obscuris, tryptophan hydroxylase messenger RNA levels per single cell signifcantly increased by 30% yet levels per brain section did not change. Comparison of tryptophan hydroxylase messenger RNA levels per cell and per brain section indicated a serotonergic loss between postnatal days 22 and 61 in both the dorsal raphe nucleus and nucleus raphe obscuris and may reflect either a loss of neurotransmitter phenotype or cell death. This study is the first to characterize the expression of brain tryptophan hydroxylase messenger RNA during rat development. In addition, this study is the first to report the activity of tryptophan hydroxylase in the spinal cord and hippocampus in the embryonic and neonatal rat. Together, the data provide a better understanding of the intricate relationship between patterns of tryptophan hydroxylase messenger RNA expression and enzyme activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113315     DOI: 10.1016/s0306-4522(00)00402-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

1.  Interaction between tryptophan hydroxylase I polymorphisms and childhood abuse is associated with increased risk for borderline personality disorder in adulthood.

Authors:  Scott T Wilson; Barbara Stanley; David A Brent; Maria A Oquendo; Yung-yu Huang; Fatemeh Haghighi; Colin A Hodgkinson; J John Mann
Journal:  Psychiatr Genet       Date:  2012-02       Impact factor: 2.458

2.  Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.

Authors:  Dorota Maciag; Kimberly L Simpson; David Coppinger; Yuefeng Lu; Yue Wang; Rick C S Lin; Ian A Paul
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

3.  Neonatal Serotonin Depletion Induces Hyperactivity and Anxiolytic-like Sex-Dependent Effects in Adult Rats.

Authors:  Luis C Reis; André S Mecawi; Verónica Trujillo; Evandro Valentim-Lima; Rodrigo Mencalha; Quézia S R Carbalan; Raoni C Dos-Santos; Viviane Felintro; Carlos E N Girardi; Rodrigo Rorato; Danilo Lustrino
Journal:  Mol Neurobiol       Date:  2020-10-20       Impact factor: 5.590

4.  Median and dorsal raphe neurons are not electrophysiologically identical.

Authors:  Sheryl G Beck; Yu-Zhen Pan; Adaure C Akanwa; Lynn G Kirby
Journal:  J Neurophysiol       Date:  2003-10-22       Impact factor: 2.714

5.  The tryptophan hydroxylase-1 A218C polymorphism is associated with diagnosis, but not suicidal behavior, in borderline personality disorder.

Authors:  Scott T Wilson; Barbara Stanley; David A Brent; Maria A Oquendo; Yung-yu Huang; J John Mann
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-03-05       Impact factor: 3.568

6.  Early life stress and novelty seeking behavior in adolescent monkeys.

Authors:  Karen J Parker; Kimberly L Rainwater; Christine L Buckmaster; Alan F Schatzberg; Steven E Lindley; David M Lyons
Journal:  Psychoneuroendocrinology       Date:  2007-07-02       Impact factor: 4.905

7.  Postnatal changes in tryptophan hydroxylase and serotonin transporter immunoreactivity in multiple brainstem nuclei of the rat: implications for a sensitive period.

Authors:  Qiuli Liu; Margaret T T Wong-Riley
Journal:  J Comp Neurol       Date:  2010-04-01       Impact factor: 3.028

8.  Vardenafil increases cell proliferation in the dentate gyrus through enhancement of serotonin expression in the rat dorsal raphe.

Authors:  Tae-Soo Kim; Il-Gyu Ko; Yun-Hee Sung; Sung-Eun Kim; Bo-Kyun Kim; Seung-Kook Park; Mal-Soon Shin; Chang-Ju Kim; Sang-Jin Yoon; Khae-Hawn Kim
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

9.  Role of NAD(+), Oxidative Stress, and Tryptophan Metabolism in Autism Spectrum Disorders.

Authors:  Musthafa Mohamed Essa; Selvaraju Subash; Nady Braidy; Samir Al-Adawi; Chai K Lim; Tamilarasan Manivasagam; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2013-07-21

10.  Modeling of the hypothalamic-pituitary-adrenal axis-mediated interaction between the serotonin regulation pathway and the stress response using a Boolean approximation: a novel study of depression.

Authors:  Oscar Andrés Moreno-Ramos; Maria Claudia Lattig; Andrés Fernando González Barrios
Journal:  Theor Biol Med Model       Date:  2013-10-05       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.